FMR CORP 13D/13G Filings for DICE Therapeutics, Inc. (DICE)

FMR CORP 13D and 13G filings for DICE Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-07-10
10:20 am
Sale		 2023-07-07 13G DICE Therapeutics, Inc.
DICE		 FMR CORP 2,239,223
4.688%		 -2,958,134decrease
(-56.92%)		 Filing
2023-02-09
09:59 am
Sale		 2023-02-09 13G DICE Therapeutics, Inc.
DICE		 FMR CORP 5,197,357
10.902%		 -96,658decrease
(-1.83%)		 Filing
2022-11-10
11:55 am
Purchase		 2022-11-09 13G DICE Therapeutics, Inc.
DICE		 FMR CORP 5,294,015
11.107%		 5,294,015increase
(New Position)		 Filing